LINE OF CREDIT LETTER AGREEMENTCredit Letter Agreement • December 19th, 2017 • Galectin Therapeutics Inc • Pharmaceutical preparations • Nevada
Richard E. Uihlein, an individual resident of the State of Illinois (“Uihlein”), hereby confirms that he is holding available to Galectin Therapeutics, Inc., a Nevada corporation (the “Company”), subject to the restrictions outlined below, a line of credit to finance the Company’s working capital needs in the amount of $10,000,000 (the “Line of Credit”). Advances made hereunder may be made by Uihlein or such other lenders, as may be identified in writing by Uihlein within one hundred eighty (180) days of the date hereof, and who become a party to this Line of Credit Agreement by execution of the Joinder Agreement on Exhibit D hereof.
